Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-02-20 @ 1:34 PM
Study NCT ID:
NCT02201303
Status:
COMPLETED
Last Update Posted:
2017-05-09
First Post:
2014-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression
Sponsor:
GlaxoSmithKline
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Infections, Respiratory Syncytial Virus | View |